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Ventilator-induced lung injury and ventilator-induced
diaphragmatic dysfunction are major complications in
mechanically ventilated patients with acute respiratory
failure. Invasive ventilation adds a further burden by
increasing the risk of infections. An approach that
protects both lung and diaphragm is pivotal. Mirabella
and colleagues compared conventional controlled
ventilation with a mode that combines several
potentially lung-protective properties - non-invasively
applied neurally adjusted ventilatory assist - in an
animal experiment. This approach seemed to be as
effective but potentially more lung-protective.
Although the experimental setup and results cannot
be translated directly to the clinical setting, they
should motivate us to further study this innovative
approach.nificant derecruitment and severe hypoxemia [10]. Com-Introduction
In the previous issue of Critical Care, Mirabella and col-
leagues [1] studied the lung-protective capabilities of non-
invasively applied neurally adjusted ventilatory assist
(NAVA) in acute respiratory failure (ARF) in an animal
study. In ARF, mechanical ventilation is applied to main-
tain adequate gas exchange, to stabilize the alveolar space,
and to unload the respiratory muscles. The price to pay is,
first and foremost, ventilator-induced lung injury (VILI).
‘Protective’ strategies using low tidal volumes and limited
airway pressures in combination with positive end-
expiratory pressure (PEEP) have been able to show a grad-
ual reduction of VILI, thus influencing outcome [2]. In
addition to VILI, controlled mechanical ventilation causes
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2014and ventilator-induced diaphragmatic dysfunction (VIDD)
[3,4]. Both VILI and VIDD have major implications for
morbidity and mortality.
NAVA provides airway pressures proportional to the
electrical activity of the diaphragm during inspiration,
ensures efficient patient-ventilator synchrony, and main-
tains the degree of biovariability that corresponds to the
actual status of the patient [5-9]. These properties not
only might be lung-protective but also might enable a
more physiologic distribution of ventilation within the
lungs, leading to improved matching of ventilation and
perfusion.
The (at least) initial use of non-invasive ventilation
(NIV) in hypercapnic ARF with respiratory muscle
weakness is a well-accepted medical standard; in con-
trast, its use in hypoxemic failure (adult respiratory dis-
tress syndrome, or ARDS) is limited because even a very
short loss of end-expiratory pressure might lead to sig-
bining the effect of these two different approaches (NIV-
NAVA), the study by Mirabella and colleagues provides
new conceptual insights into lung-protective ventilation
[1].
Hypothesis, results and open questions
Based on the hypothesis that NIV-NAVA (without exter-
nal PEEP) might be equally protective, the authors com-
pared it with conventional invasive mechanical
ventilation (tidal volume of 6 mL/kg and PEEP of 5 cm
H2O) with neuromuscular blockade in an animal experi-
ment with acid-induced ARF (arterial partial pressure of
oxygen/fraction of inspired oxygen ratio of less than
200) [1]. At 6 hours, both groups recovered to oxygen-
ation values found before injury. Only the NIV-NAVA
group demonstrated an improvement in the dynamic
compliance; consequently, lower peak and plateau pres-
sures were measured and lung injury was less pro-
nounced in NIV-NAVA as proven by inflammatory
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of spontaneous breathing, upper airway liberation, and
variable breathing pattern. The approach of this study
is innovative and, to some extent, challenges the iron
law that, in ARDS states comparable to those experi-
mentally induced in this study, intubation and con-
trolled mechanical ventilation are the only appropriate
options.
The study, though presenting challenging results, has
obvious limitations, foremost relating the findings to one
well defined, specific intervention. This is true for two
reasons. First, the study compares two different modes
of mechanical ventilation: volume-controlled mechanical
ventilation in paralyzed, deeply sedated subjects and
assisted mechanical ventilation applied with NAVA. Sec-
ond, it compares two different interfaces by which
mechanical ventilation is applied: invasive mechanical
ventilation via an endotracheal tube and NIV applied via
a nasal prong.
A group of non-invasive pressure support ventilated
animals would have allowed us to better understand and
interpret the results, but (as stated by the authors) this
was technically not achievable.
Before open NIV-NAVA can be considered in the clin-
ical setting, a number of questions presented by the
complexity of the topic have to be answered:
1. Do the positive effects prevail over a longer period
of time? In a setting where positive effects have to
persist and side effects might need time to develop
their detrimental effects, an observation period of
6 hours is too short.
2. Is persistent tonic activity less injurious than the
application of PEEP? PEEP has a direct effect on
respiratory muscle load, recruitment, and pulmonary
gas exchange; it reduces alveolar cycling and
influences the respiratory drive [11]. Tonic activity
of the diaphragm describes a persistently increased
activity during the expiratory phase [12,13]. The
data presented suggest that, in a setting without
external PEEP, increased tonic diaphragmatic activity
enables recruitment and enlarges end-expiratory
lung volume. The observation that increased tonic
diaphragmatic activity induced effects comparable to
those of controlled mechanical ventilation with a
PEEP of 5 cm H2O underlines the importance of
non-prima vista effects of NAVA that might open
new treatment options for respiratory failure. If ARF
resolves within a short period of time, preservation
of tonic activity might be an effective measure. The
long-term effect remains to be elucidated. A pro-
longed phase of induced tonic activity might fatigue
the diaphragm and induce secondary respiratory fail-
ure [13]. The increased tonic activity toward the endof the experiment, therefore, should be interpreted
with caution. It remains unclear whether open NIV-
NAVA outperforms a setting that includes externally
applied PEEP. Consequently, Mirabella and col-
leagues do not suggest the use of zero PEEP in the
clinical setting.
3. Are the findings transferable to a more stable severe
ARDS and increased respiratory drive? The
preservation of spontaneous breathing has marked
beneficial effects [14]. However, by increasing the
forces applied to the lung, an unsuppressed, severely
increased respiratory drive might be harmful [15]. In
states of severe hypoxemia, the question of whether
to put the patient at rest or to admit his or her own
respiratory drive remains unanswered.
Twenty percent regurgitation in the NIV group would
be unacceptable in clinical routine. This finding, how-
ever, should be interpreted with caution since the sed-
ation level required to enable the animal experiment
might account for this side effect.
Conclusions
This experimental study by Mirabella and colleagues of-
fers interesting insights into the potentials of NIV-
NAVA [1]. It is encouraging that NIV-NAVA has effect-
ively maintained a state in which pulmonary gas
exchange was seemingly more protective than conven-
tional invasive ventilation. Thus, in a reversible injury
with fast recovery and low tendency for derecruitment,
open NIV-NAVA seems beneficial since it offers the op-
portunity to avoid controlled mechanical ventilation and
intubation. Being applied with uncontrollable leakage
underlines the properties and potentials of NAVA and
should encourage further studies with NIV-NAVA to de-
fine its indications in the clinical setting.
However, we would like to state that this study chal-
lenges accepted limits or standard of care in several
ways. In light of the current standard of routine care in
patients who resemble the chosen experimental setup
(moderate ARDS), the findings should be weighed care-
fully before being translated to clinical practice. As
noted by the authors themselves, NIV should be restrict-
ively used in patients with hypoxemic respiratory failure,
and its application without PEEP cannot be advised at
this stage.
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